MRI PET-CT
Showing 1 - 25 of >10,000
Gliomas Using Radiomic Analysis
Not yet recruiting
- Glioma
- Radiomic analysis of imaging - MRI, PET, CT
- (no location specified)
Sep 6, 2023
Hepatocellular Carcinoma Trial in Aarhus (18F-FDGal PET/CT or PET/MRI)
Not yet recruiting
- Hepatocellular Carcinoma
- 18F-FDGal PET/CT or PET/MRI
-
Aarhus, DenmarkAarhus University Hospital
May 15, 2023
Prostate Cancer Trial (Piflufolastat F 18 Intravenous Solution [PYLARIFY])
Not yet recruiting
- Prostate Cancer
- Piflufolastat F 18 Intravenous Solution [PYLARIFY]
- (no location specified)
Oct 3, 2023
Von Hippel-Lindau Disease Trial (68Ga-NY104 PET/CT Contrast-enhanced MRI of the brain and contrast-enhanced CT of abdomen and
Not yet recruiting
- Von Hippel-Lindau Disease
- 68Ga-NY104 PET/CT Contrast-enhanced MRI of the brain and contrast-enhanced CT of abdomen and pelvis) 68Ga-NODAGA-LM3 PET/CT (exploratory)
- (no location specified)
Mar 30, 2023
Prostate Cancer Trial (Pylarify Piflufolastat Flourine-18 (18F-DCFPyL))
Not yet recruiting
- Prostate Cancer
- Pylarify Piflufolastat Flourine-18 (18F-DCFPyL)
- (no location specified)
Jan 26, 2023
[18F]-FDG PET/CT and PET/MRI in Lymphomas
Recruiting
- PET/MRI
-
Beijing, Card Holder's Billing State / Province, ChinaPeking University Cancer Hospital
May 22, 2022
US, MRI and PET/CT in the Assessment of LNs in Cervical Cancer.
Recruiting
- Lymph Node Metastasis
- Cervical Cancer
- ultrasound - transvaginal/transrectal + transabdominal
-
Prague, CzechiaGeneral University Hospital
Oct 5, 2022
Hepatocellular Carcinoma Trial in Rochester (Ga-68 labeled PSMA-11, Possible liver biopsy for locoregional therapy group)
Recruiting
- Hepatocellular Carcinoma
- Ga-68 labeled PSMA-11
- Possible liver biopsy for locoregional therapy group
-
Rochester, MinnesotaMayo Clinic in Rochester
Jul 18, 2022
Multiple Sclerosis Trial in Pavia (18F-florbetaben PET/CT)
Recruiting
- Multiple Sclerosis
- 18F-florbetaben PET/CT
-
Pavia, PV, ItalyICS Maugeri SpA SB IRCCS
Mar 23, 2023
Multiple Myeloma, Plasma Cell Myeloma Trial in San Francisco (drug, procedure, other)
Not yet recruiting
- Multiple Myeloma
- Plasma Cell Myeloma
- Zirconium Zr 89-DFO-YS5
- +3 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
May 26, 2023
Cytoreductive Surgery, Grade 3 Endometrial Endometrioid Adenocarcinoma, High Grade Serous Carcinoma Trial in Boston (PET/MRI
Not yet recruiting
- Cytoreductive Surgery
- +4 more
- PET/MRI with radiotracer ([18F]- fluorodeoxyglucose) and a gadolinium-based contrast agent
-
Boston, MassachusettsMassachusetts General Hospital
May 21, 2022
Multiple Sclerosis, Inflammatory Demyelinating Disease Trial in Rochester (C-11 ER176 Radiotracer, C11 Pittsburgh Compound B,
Not yet recruiting
- Multiple Sclerosis
- Inflammatory Demyelinating Disease
- C-11 ER176 Radiotracer
- +3 more
-
Rochester, MinnesotaMayo Clinic Minnesota
Mar 28, 2023
Cervical Cancer Squamous Cell Trial in Toronto (18-FDG PET/CT, DWI, DCE-MRI)
Completed
- Cervical Cancer Squamous Cell
- 18-FDG PET/CT, DWI, DCE-MRI
-
Toronto, Ontario, CanadaUniversity Health Network, The Princess Margaret
Nov 7, 2022
Biochemical Recurrence of Malignant Tumor of Prostate, Prostate Cancer, BCR Prostate Carcinoma Trial in China (68Ga-PSMA-11,
Not yet recruiting
- Biochemical Recurrence of Malignant Neoplasm of Prostate
- +2 more
- 68Ga-PSMA-11
- PET/CT or PET/MRI
-
Changsha, China
- +5 more
Apr 26, 2023
Parkinson Disease, Dementia With Lewy Bodies, MSA - Multiple System Atrophy Trial in Leuven, Gent ([18F]-MFBG PET CT,
Not yet recruiting
- Parkinson Disease
- +3 more
- [18F]-MFBG PET CT
- +3 more
-
Leuven, Vlaams-Brabant, Belgium
- +1 more
Oct 31, 2023
Hepatocellular Carcinoma Trial in Aarhus (18F-FDGal PET/CT and 18F-choline PET/CT)
Not yet recruiting
- Hepatocellular Carcinoma
- 18F-FDGal PET/CT and 18F-choline PET/CT
-
Aarhus, DenmarkAarhus University Hospital
Apr 28, 2022
Combined mpMRI and PSMA PET/CT for Highly Suspicious Patients
Not yet recruiting
- Prostatic Neoplasms
- +2 more
- (no location specified)
Jan 9, 2023
Malignant Glioma, Recurrent Brain Tumor Trial in Rochester (procedure, drug, other)
Active, not recruiting
- Malignant Glioma
- Recurrent Brain Neoplasm
- Biopsy
- +7 more
-
Rochester, MinnesotaMayo Clinic
Jan 5, 2023
Breast Cancer, Breast Carcinoma, Metastatic Breast Cancer Trial in New York (18F-FDG PET/CT, [18F]-Fluoro-2-Deoxy-D-Glucose and
Recruiting
- Breast Cancer
- +4 more
- 18F-FDG PET/CT
- +2 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Nov 17, 2023
Castration Resistant Prostate Cancer, Castration Sensitive Prostate Cancer Trial in Portland (drug, procedure, other)
Not yet recruiting
- Castration Resistant Prostate Cancer
- Castration Sensitive Prostate Cancer
- Piflufolastat
- +4 more
-
Portland, OregonOHSU Knight Cancer Institute
Jun 16, 2023
Prostate Cancer Diagnosis Trial in Los Angeles (diagnostic test, other, drug)
Not yet recruiting
- Prostate Cancer Diagnosis
- PSMA PET scan
- +2 more
-
Los Angeles, CaliforniaVA Greater Los Angeles Healthcare System
Apr 20, 2023
Multiple Myeloma, Bone Metastases Trial in Brussels (MRI)
Recruiting
- Multiple Myeloma
- Bone Metastases
- MRI
-
Brussels, BelgiumCliniques Universaires Siant Luc
May 12, 2022
Malignant Ovarian Tumor, Ovarian Carcinoma Trial in Houston (Dynamic Enhanced CT, Magnetic Resonance Imaging, Positron Emission
Recruiting
- Malignant Ovarian Neoplasm
- Ovarian Carcinoma
- Dynamic Enhanced CT
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Oct 12, 2022
Glioma Trial (PET/CT with 18F-DOPA)
Not yet recruiting
- Glioma
- PET/CT with 18F-DOPA
- (no location specified)
Aug 23, 2022
Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in San Francisco (drug, biological, procedure)
Recruiting
- Prostate Cancer
- Metastatic Castration-resistant Prostate Cancer
- 89Zr-DFO-YS5
- +3 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Mar 29, 2022